Cited by 49Blood Pressure and Hypertension StudiesRenal and Vascular PathologiesDialysis and Renal Disease Management

Renal sympathetic nerve ablation for the treatment of difficult-to-control or refractory hypertension in a haemodialysis patient

Open access
Di Daniele, N., De Francesco, M., Violo, L., Spinelli, A., Simonetti, G.·2012·Nephrology Dialysis Transplantation

Abstract

Haemodialysis patients show sympathetic hyperactivity. Hyperactivation of the sympathetic nervous system aggravates hypertension and it is related to left ventricular hypertrophy, heart failure, arrhythmias and atherogenesis. We report the first use of renal sympathetic nerve ablation for correction of uncontrolled hypertension in an end-stage renal disease patient on maintenance dialysis. We observed a progressive and sustained reduction of systemic blood pressure. Our case demonstrates the safety, the feasibility and the efficacy of this procedure. These findings suggest, however, that further clinical trials are needed into renal nerve radiofrequency ablation therapy for the treatment of hypertension and for the improvement of cardiovascular prognosis in this high-risk patient group.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/ndt/gfs044

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Small studies and case reports show that renal denervation reduces blood pressure and is safe in patients with kidney failure on haemodialysis.

    “a small clinical trial in 24 patients with kidney failure on haemodialysis confirmed the safety of the procedure in these patients and demonstrated that RDN resulted in significant reductions in DBP and SBP that persisted for at least 12 months64.”

    From Renal nerves in physiology, pathophysiology and interoception (2025) · cites this paper as [120]

    The Abstract reports lower systolic and diastolic blood pressure one month after renal denervation in a single haemodialysis patient. It describes a case report, not a 24-patient clinical trial, and does not establish procedural safety or blood-pressure reductions lasting at least 12 months. (LLM, conf=0.90)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Di Daniele, N., De Francesco, M., Violo, L., Spinelli, A., & Simonetti, G.
Affiliations
University of Rome Tor Vergata (IT)
Venue
Nephrology Dialysis Transplantation
Published
2012-03-29
Volume
27
Issue
4
Pages
1689-1690
ISSN
  • 0931-0509 (ISSN-L)
  • 1460-2385
OpenAlex
W2114547337
Cited by
49
References
3
Citations by year
2025: 1 · 2024: 3 · 2023: 2 · 2022: 1 · 2020: 1 · 2019: 1 · 2018: 2 · 2017: 5 · 2016: 2 · 2015: 5 · 2014: 8 · 2013: 14 · 2012: 4
FWCI
6.38
Type
journal article
Language
en
Open access
Locations
  • Nephrology Dialysis Transplantation (publishedVersion)
  • PubMed (publishedVersion)
  • Cineca Institutional Research Information System (Tor Vergata University) (submittedVersion, other-oa)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Renal and Vascular Pathologies
  • Health Sciences › Medicine › Nephrology › Dialysis and Renal Disease Management
Keywords
resistant hypertension, hemodialysis, end-stage renal disease, sympathetic hyperactivity, radiofrequency ablation, blood pressure reduction, cardiovascular risk
MeSH terms
Adult, Renal Dialysis, Humans, Hypertension, Kidney Failure, Chronic, Prognosis, Renal Artery, Sympathectomy, Sympathetic Nervous System, Catheter Ablation, Blood Pressure Monitoring, Ambulatory

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review